COVID-19
NIH-funded study finds long COVID affects adolescents differently than younger children
Adolescents were most likely to experience low energy/tiredness while children were most likely to report headache. Novel Coronavirus SARS-CoV-2 (Omicron) Colorized scanning electron micrograph of a cell (pink) infected with the Omicron strain of SARS-CoV-2 virus particles (yellow), isolated from a patient sample. Image captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland.NIAID Scientists investigating long COVID in youth found similar but distinguishable patterns between school-age children (ages 6-11 years) and adolescents (ages 12-17 years) and identified their most common symptoms. The study, supported by the National Institutes of Health (NIH) and published in JAMA, comes from research conducted through the NIH’s Researching COVID to Enhance Recovery (RECOVER) Initiative(link is external), a wide-reaching effort to understand, diagnose, treat, and prevent long COVID, a condition marked by symptoms and health problems that linger after an infection with SARS-CoV-2, the virus that causes COVID-19.
SARS-CoV-2 infects coronary arteries, increases plaque inflammation
SARS-CoV-2, the virus that causes COVID-19, can directly infect the arteries of the heart and cause the fatty plaque inside arteries to become highly inflamed, increasing the risk of heart attack and stroke, according to a study funded by the National Institutes of Health.
Large study provides scientists with deeper insight into long COVID symptoms
Initial findings from a study of nearly 10,000 Americans, many of whom had COVID-19, have uncovered new details about long COVID, the post-infection set of conditions that can affect nearly every tissue and organ in the body.
COVID-19 Disrupts Gut Microbes
Microbes live all over your body. These include bacteria, fungi, and viruses. People with COVID-19 often have an imbalance in their gut’s microbes.
https://newsinhealth.nih.gov/2023/02/covid-19-disrupts-gut-microbes
NIH establishes website for self-reporting COVID-19 test results
Reporting a positive or negative test result just became easier through a new website from the National Institutes of Health.
https://www.nih.gov/news-events/news-releases/nih-establishes-website-self-reporting-covid-19-test-results
Understanding long-term COVID-19 symptoms and enhancing recovery
We are in the third year of the COVID-19 pandemic, and across the world, most restrictions have lifted, and society is trying to get back to “normal.” But for many people—potentially millions globally—there is no getting back to normal just yet.
https://directorsblog.nih.gov/2022/03/01/how-covid-19-immunity-holds-up-over-time/
Scientists identify characteristics to better define long COVID
Using machine learning, researchers find patterns in electronic health record data to better identify those likely to have the condition.
https://directorsblog.nih.gov/2022/03/01/how-covid-19-immunity-holds-up-over-time/
COVID-19
How COVID-19 Immunity Holds Up Over Time
https://directorsblog.nih.gov/2022/03/01/how-covid-19-immunity-holds-up-over-time/
COVID-19
Researchers highlight COVID-19 neurological symptoms
COVID-19
Learning to Protect Communities with COVID-19 Home Testing Programs. With most kids now back in school, parents face a new everyday concern: determining whether their child’s latest cough or sneeze might be a sign of COVID-19.
Breakthrough Infections in Vaccinated People Less Likely to Cause 'Long COVID'
There’s no question that vaccines are making a tremendous difference in protecting individuals and whole communities against infection and severe illness from SARS-CoV-2, the coronavirus that causes COVID-19. And now, there’s yet another reason to get the vaccine…
NIH to support radical approaches to nationwide COVID-19 testing and surveillance
The National Institutes of Health has awarded over $107 million to support new, non-traditional approaches and reimagined uses of existing tools to address gaps in COVID-19 testing and surveillance. The program also will develop platforms that can be deployed in future outbreaks of COVID-19 and other infectious diseases.
Planning Your Holidays During the COVID-19 Pandemic
With the holiday season fast approaching and coronavirus disease 2019 (COVID-19) surging in most parts of the country, millions of Americans—including me and my family—will break with tradition this year to celebrate in ways that we hope will help to keep us all safe and healthy.
https://directorsblog.nih.gov/2020/11/12/planning-your-holidays-during-the-covid-19-pandemic/
Study Highlights Need for Continued Care of COVID-19 Survivors
The past several months have shown that most people hospitalized with COVID-19 will get better. As inspiring as it is to see these patients breathe on their own and converse with their loved ones again, we are learning that many will leave the hospital still quite ill and in need of further care.
Building Resilience During the COVID-19 Pandemic
Dating back to our earliest times, humankind has experienced the psychological impact of a wide range of catastrophes, including famines, floods, earthquakes, wildfires, windstorms, wars, and, last but certainly not least, outbreaks of potentially deadly infectious diseases. We are certainly no exception today as people try to figure out how to cope—
https://directorsblog.nih.gov/2020/10/15/building-resilience-during-the-covid-19-pandemic/
How COVID-19 Took Hold in North America
It was nearly 10 months ago on January 15 that a traveler returned home to the Seattle area after visiting family in Wuhan, China.
https://directorsblog.nih.gov/2020/09/22/how-covid-19-took-hold-in-north-america-and-europe/
Coronavirus Antibodies
There’s been a lot of excitement about the potential of antibody-based blood tests, also known as serology tests, to help contain the coronavirus disease 2019 (COVID-19) pandemic.
NIH begins study to quantify undetected cases of coronavirus infection
The presence of antibodies in the blood indicates a prior infection. In this “serosurvey,” researchers will collect and analyze blood samples from as many as 10,000 volunteers to provide critical data for epidemiological models.
A potential therapy for COVID-19
A clinical trial to evaluate the safety and effectiveness of hydroxychloroquine for the treatment of adults hospitalized with coronavirus disease 2019 (COVID-19) has begun, with the first participants now enrolled in Tennessee.
To Beat COVID-19, Social Distancing is a Must
Even in less challenging times, many of us try to avoid close contact with someone who is sneezing, coughing, or running a fever to avoid getting sick ourselves. Our attention to such issues has now been dramatically heightened by the emergence of a novel coronavirus causing a pandemic of an illness known as COVID-19.
https://directorsblog.nih.gov/2020/03/19/to-beat-covid-19-social-distancing-is-a-must/